Retinopathy of Prematurity (ROP) Recruiting Phase 2 Trials for Bevacizumab (DB00112)

Also known as: ROP - Retinopathy of Prematurity / Retinopathy of Prematurity / Retrolental fibroplasia / Retinopathy of prematurity (disorder) / Retinopathy of prematurity NOS / Retrolental fibroplasia (disorder)

IndicationStatusPhase
DBCOND0046296 (Retinopathy of Prematurity (ROP))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04634578Bevacizumab Treatment For Posterior Zone I ROPTreatment